Anglo-French Drugs & Industries Ltd. (AFD Pharma) is a global pharmaceutical company with a rich history dating back to 1923. The company has been a pioneer in manufacturing nutritional healthcare products in India, being the first to produce single vitamin injections and a combination of B-complex vitamins in the country. Anglo-French has evolved into a dynamic, rapidly expanding pharmaceutical company, developing therapeutic formulations and distributing them worldwide. The company's commitment to addressing unmet medical needs through expertise and perfection has been the driving force behind its success. Quality is emphasized as the key factor for success, with stringent standards to ensure consistent safety, effectiveness, and good quality across all products. With a workforce of nearly 1000 people, Anglo-French serves over 65,000 doctors, 50,000 chemists, and other affiliated parties. They have market-leading brands in nutraceuticals, CNS, skin, and respiratory segments, and are focused on building next-generation pharmaceutical solutions for the health and well-being of the Indian population. The company is committed to delivering exceptional quality and meeting the ever-changing needs of its customers as it looks forward to the next 100 years. Overall, Anglo-French Drugs & Industries Ltd. is a reputable pharmaceutical company with a strong history and a commitment to innovation and impact on people's lives.
There is no investment information
No recent news or press coverage available for Anglo-French Drugs & Industries Ltd..